跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Dapagliflozin Tablets
Approved
化学药品
Dapagliflozin Tablets
m/s. hetero labs limited
🇨🇳 National Medical Products Administration
Approval Date
Mar 18, 2025
Approval ID
8iAhWbZMrWM
Company
m/s. hetero labs limited
Type
化学药品
Approval Details
Approval Id
8iAhWbZMrWM
Approval Number
国药准字HJ20250029
Generic Name
达格列净片
Generic Name En
Dapagliflozin Tablets
Drug Type
化学药品
Dosage Form
片剂
Strength
5mg(按C₂₁H₂₅ClO₆计)
Reg Date
2025-03-18
Expired Date
2030-03-17
Company Name
m/s. hetero labs limited
Company Address
Unit-III, 22-110, I.D.A, Jeedimetla (V), Quthbullapur (M), Medchal-Malkajgiri (Dist.), 500 055, Telangana State, India
Production Company Name
m/s. hetero labs limited
Production Company Address
Unit-III, 22-110, I.D.A, Jeedimetla (V), Quthbullapur (M), Medchal-Malkajgiri (Dist.), 500 055, Telangana State, India
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Mar 18, 2025
Approval ID
8iAhWbZMrWM
Type
化学药品
Back to NMPA Approvals
达格列净片 - NMPA Drug Approval Details